Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials

Background: The 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) protocol provides superior oncologic results compared to other perioperative chemotherapeutic protocols for the treatment of non-metastatic esophagogastric cancer (EGAC). Survival and the pattern of recurrence of EGAC after FLOT and...

Descripción completa

Detalles Bibliográficos
Autores principales: Glatz, Torben, Verst, Rasmus, Kuvendjiska, Jasmina, Bronsert, Peter, Becker, Heiko, Hoeppner, Jens, Kulemann, Birte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464040/
https://www.ncbi.nlm.nih.gov/pubmed/32824326
http://dx.doi.org/10.3390/jcm9082654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464040/
https://www.ncbi.nlm.nih.gov/pubmed/32824326
http://dx.doi.org/10.3390/jcm9082654

Ejemplares similares